Intelligent Bio Solutions Inc. (INBS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $5.84M
Last updated: Nov 17, 2026 at 11:03 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 14.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 40.1, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about INBS
News
INBS Valuation
INBS Profitability: Margins, ROIC and FCF
Intelligent Bio Solutions (INBS) has a gross margin of 50.9%, an operating margin of -272.6% and a net margin of -269.3%. It posts a -265.0% FCF margin.
- Gross margin
- 50.9%
- Operating margin
- -272.6%
- Net margin
- -269.3%
- ROE
- -225.3%
- FCF margin
- -265.0%
- FCF yield
- -253.2%
Intelligent Bio Solutions Competitors
The companies most similar to Intelligent Bio Solutions (INBS) include Trinity Biotech, Volitionrx and Neuroone Medical Technologies.
Sector: Healthcare
Companies most similar to Intelligent Bio SolutionsINBS Bull Case vs Bear Case
Bull case
- INBS grew quarterly revenue 25.2% year over year.
Bear case
- INBS has a -269.3% net profit margin.
- INBS beat EPS estimates in 12.5% of its last 8 reported quarters.
INBS Earnings: Beat Rate and Next Report
Intelligent Bio Solutions (INBS) beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate (12.5%).
- Beat rate
- 1 of 8 quarters (12.5%)
- Average surprise
- -185.6%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$1.36
- Estimate revisions (30 days, fiscal period ending Dec 31, 2026)
- 0 up, 0 down
INBS ETF Holders
GNG tracks 1 ETF that holds INBS.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About INBS
Does INBS pay dividends?
Intelligent Bio Solutions Inc. (INBS) does not currently pay a regular dividend.
What is INBS's market cap?
Intelligent Bio Solutions Inc. (INBS) has a market capitalization of $5.84M with a current stock price of $1.52.
INBS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.